IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 632,000 (47%) | — | ₹114 Cr |
| Retail | — | 632,000 (47%) | — | ₹114 Cr |
| Market Maker | — | 72,000 (5%) | — | ₹1 Cr |
| Σ Total | — | 1,336,000 (100%) | — | ₹2,405 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 8,000 | ₹144,000 |
| Retail (Max) | 13 | 104,000 | ₹1,872,000 |
| S-HNI (Min) | 14 | 112,000 | ₹2,016,000 |
| B-HNI (Min) | 67 | 536,000 | ₹9,648,000 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Working Capital Requirements – 1.60
- General Corporate Purpose – 0.40
Company Overview
Incorporated in 1996, Chemcrux Enterprises Ltd (CEL) is an ISO 9001:2008 and ISO 14001:2004 certified company, engaged in high pressure Oxidation, Chlorosulfonation, Nitration and Aceylation forb manufacturing of intermediates for bulk drugs, dyes and pigments.
Comapany is also exports its products to Europe, Egypt and United States of America. It also caters to customers with tailor made products. CE's major selling products are Lassamide, various Chloro Benzoic acids and Nitro Benzoic acids.